METHODS AND SYSTEMS OF EVALUATING RISK OF LUNG CANCER Russian patent published in 2019 - IPC A61B5/08 A61B5/145 G01N33/49 

FIELD: computing; counting.

SUBSTANCE: group of inventions relates to medicine, specifically to the diagnosis of malignant tumours, and can be used to assess the risk of lung cancer. System comprises a computer readable medium for implementing a computerised method, comprising: generating a set of features comprising a plurality of current blood test results from blood collected from a target individual; providing at least one classifier generated according to an analysis of a plurality of respective historical blood test results of each of another of a plurality of sampled individuals; creating a combination of at least 10 raw features based on said set of current blood test results, wherein said at least 10 raw features include the current values of blood tests, at least 10 results of various blood tests; and evaluating, using a processor, a lung cancer risk of said target individual by classifying said combination of at least 10 raw features of current blood test values, at least 10 results of various blood tests using said at least one classifier; each of said plurality of historical and current blood test results includes the results of at least one biochemical analysis result and the current values of blood tests selected from each of the following groups of blood tests: (i) white blood cells blood test results including at least one of neutrophils count, basophils count, eosinophils count, lymphocytes count, monocytes count, WBC count, neutrophils percentage, basophils percentage, eosinophils percentage, lymphocytes percentage, and monocytes percentage, wherein said set of features comprises a plurality of historical blood test results from said blood collected from said target individual; (ii) platelets blood test results including at least one of platelets count and mean platelet volume (MPV); and a combination of (iii) smoking history and (iv) red cell test results including at least one of red blood cells (RBC), red cell distribution width (RDW), blood tests hemoglobin (MCH), mean cell volume (MCV), mean corpuscular hemoglobin concentration (MCHC), hematocrit, and hemoglobin.

EFFECT: group of inventions provides effective cancer screening.

15 cl, 2 dwg